Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Merck & Co Inc (NYSE:MRK)

65.13
Delayed Data
As of Sep 22
 -0.47 / -0.72%
Today’s Change
58.29
Today|||52-Week Range
66.80
+10.63%
Year-to-Date
US Market Indexes Mostly Higher
Sep 22 / GuruFocus News - Paid Partner Content
Pfizer Sues J&J, Accuses it of Preventing Inflectra Uptake
Sep 21 / Zacks.com - Paid Partner Content
Gilead's (GILD) Epclusa Receives Label Expansion in Canada
Sep 22 / Zacks.com - Paid Partner Content
2 Important Dates for Big Pharma
Sep 20 / GuruFocus News - Paid Partner Content
Pfizer-Merck KGaA Skin Cancer Drug Bavencio Gets EU Approval
Sep 22 / Zacks.com - Paid Partner Content
Roche (RHHBY) Announces Positive Data on Leukemia Drug
Sep 19 / Zacks.com - Paid Partner Content
Dow 30 Stock Roundup: BA Wins $600M Air Force Contract, JPM Invests in Bill.com
Sep 22 / Zacks.com - Paid Partner Content
Roche's (RHHBY) Tecentriq Studies Put on Partial Hold by FDA
Sep 18 / Zacks.com - Paid Partner Content
Cancer Space Update: Mixed Week for Pfizer, Roche Falters
Sep 22 / Zacks.com - Paid Partner Content
Oncology Space in Focus this Week on ESMO Presentations
Sep 15 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close65.60
Today’s open65.63
Day’s range65.07 - 65.70
Volume7,465,921
Average volume (3 months)8,204,535
Market cap$177.6B
Dividend yield2.89%
Data as of 09/22/2017

Growth & Valuation

Earnings growth (last year)-9.62%
Earnings growth (this year)+2.38%
Earnings growth (next 5 years)+6.00%
Revenue growth (last year)+1.86%
P/E ratio35.2
Price/Sales4.15
Price/Book4.47

Competitors

 Today’s
change
Today’s
% change
NVSNovartis+1.22+1.44%
PFEPfizer-0.01-0.03%
SNYSanofi+0.39+0.78%
ABBVAbbVie+0.07+0.08%
Data as of 4:02pm ET, 09/22/2017

Financials

Next reporting dateOctober 27, 2017
EPS forecast (this quarter)$1.03
Annual revenue (last year)$39.5B
Annual profit (last year)$3.9B
Net profit margin9.93%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman, President &
Chief Executive Officer
Kenneth C. Frazier
CFO &
Executive Vice President-Global Services
Robert M. Davis
Corporate headquarters
Kenilworth, New Jersey

Forecasts